William Blair Issues Negative Estimate for Repligen Earnings
Repligen Co. (NASDAQ:RGEN – Free Report) – Research analysts at William Blair decreased their Q2 2025 earnings per share (EPS) estimates for Repligen in a research report issued on Wednesday, April 30th. William Blair analyst M. Larew now anticipates that the biotechnology company will earn $0.41 per share for the quarter, down from their prior […]
Repligen Co. (NASDAQ:RGEN – Free Report) – Research analysts at William Blair decreased their Q2 2025 earnings per share (EPS) estimates for Repligen in a research report issued on Wednesday, April 30th. William Blair analyst M. Larew now anticipates that the biotechnology company will earn $0.41 per share for the quarter, down from their prior […]
